Back to search
FDAFDA · Food and drugs·Recall number D-0118-2021

REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPM Medical Mesquite, TX 75149. NDC 66977-107-03

Published December 9, 2020 · Recall initiated: November 17, 2020

Summary

FDA records drug Class I recall D-0118-2021, published December 9, 2020 and initiated November 17, 2020. Recalling firm: MPM Medical LLC; Status: Terminated; Reported quantity: 7,637 tubes; Lot: Lot: 41262 Exp. 01/21. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.

What to do

Voluntary: Firm initiated · Letter

Get an email if REGENECARE HA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
REGENECARE HA
Manufacturer
MPM Medical LLC
Distributor
Distributed Nationwide in the USA
UPC
0366977112055
Lot
Lot: 41262 Exp. 01/21
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPM Medical Mesquite, TX 75149. NDC 66977-107-03 recalled?

Yes. FDA published recall D-0118-2021 on December 9, 2020. Reported hazard: Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: REGENECARE HA. UPC: 0366977112055.